The DOI matches its Crossref record; 464 of the 464 references it cites were found in a registry or an index.
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Abstract
BACKGROUND: Metformin is an oral anti-hyperglycemic agent that has been shown to reduce total mortality compared to other anti-hyperglycemic agents, in the treatment of type 2 diabetes mellitus. Metformin, however, is thought to increase the risk of lactic acidosis, and has been considered to be contraindicated in many chronic hypoxemic conditions that may be associated with lactic acidosis, such as cardiovascular, renal, hepatic and pulmonary disease, and advancing age. OBJECTIVES: To assess the incidence of fatal and nonfatal lactic acidosis, and to evaluate blood lactate levels, for those on metformin treatment compared to placebo or non-metformin therapies. SEARCH STRATEGY: A comprehensive search was performed of electronic databases to identify studies of metformin treatment. The search was augmented by scanning references of identified articles, and by contacting principal investigators. SELECTION CRITERIA: Prospective trials and observational cohort studies in patients with type 2 diabetes of least one month duration were included if they evaluated metformin, alone or in combination with other treatments, compared to placebo or any other glucose-lowering therapy. DATA COLLECTION AND ANALYSIS: The incidence of fatal and nonfatal lactic acidosis was recorded as cases per patient-years, for metformin treatment and for non-metformin treatments. The upper limit for the true incidence of cases was calculated using Poisson statistics. In a second analysis lactate levels were measured as a net change from baseline or as mean treatment values (basal and stimulated by food or exercise) for treatment and comparison groups. The pooled results were recorded as a weighted mean difference (WMD) in mmol/L, using the fixed-effect model for continuous data. MAIN RESULTS: Pooled data from 347 comparative trials and cohort studies revealed no cases of fatal or nonfatal lactic acidosis in 70,490 patient-years of metformin use or in 55,451 patients-years in the non-metformin group. Using Poisson statistics the upper limit for the true incidence of lactic acidosis per 100,000 patient-years was 4.3 cases in the metformin group and 5.4 cases in the non-metformin group. There was no difference in lactate levels, either as mean treatment levels or as a net change from baseline, for metformin compared to non-metformin therapies. AUTHORS' CONCLUSIONS: There is no evidence from prospective comparative trials or from observational cohort studies that metformin is associated with an increased risk of lactic acidosis, or with increased levels of lactate, compared to other anti-hyperglycemic treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 464
Nattrass, M., Todd, P. G., Hinks, L. J., Lloyd, B. B., & Alberti, K. G. M. M. (1977) · Diabetologia · doi:10.1007/bf00745143 · Cited by 72
Wolever, T., Chiasson, J.-L., Josse, R., Hunt, J., Palmason, C., Rodger, N., Ross, S., Ryan, E., & Tan, M. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800468 · Cited by 71
Kim, H. J., Kang, E. S., Kim, D. J., Kim, S. H., Ahn, C. W., Soo, B., Nam, M., Chung, C. H., Lee, K. W., Nam, C. M., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02723.x · Cited by 71
Weissman, P. N., Goldstein, B. J., Rosenstock, J., Waterhouse, B. R., Cobitz, A. R., Wooddell, M. J., & Strow, L. J. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x74844 · Cited by 71
Comparison of Tolbutamide and Metformin in Elderly Diabetic Patients
Josephkutty, S., & Potter, J. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01433.x · Cited by 71
Cefalu, W. T., Schneider, D. J., Carlson, H. E., Migdal, P., Lim, L. G., Izon, M. P., Kapoor, A., Bell–Farrow, A. D., Terry, J. G., & Sobel, B. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2123 · Cited by 71
Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study
Kamber, N., Davis, W. A., Bruce, D. G., & Davis, T. M. E. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01713.x · Cited by 70
Roberts, V. L., Stewart, J. A., Issa, M., Lake, B., & Melis, R. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.10.017 · Cited by 68
Abbasi, F., Kamath, V., Rizvi, A. A., Carantoni, M., Chen, Y. I., & Reaven, G. M. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1863 · Cited by 68
Palumbo, P. J. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00053-6 · Cited by 67
Goldstein, B. J., Pans, M., & Rubin, C. J. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80112-1 · Cited by 67
Tosi, F., Muggeo, M., Brun, E., Spiazzi, G., Perobelli, L., Zanolin, E., Gori, M., Coppini, A., & Moghetti, P. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00101-x · Cited by 66
Carter, A. M., Bennett, C. E., Bostock, J. A., & Grant, P. J. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01632.x · Cited by 66
Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin.
Riccio, A., Prato, S. D., de Kreutzenberg, S. V., & Tiengo, A. (1991) · PubMed · Cited by 66
Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: A meta-analysis
Monami, M., Lamanna, C., Marchionni, N., & Mannucci, E. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.08.024 · Cited by 65
Combined metformin and insulin therapy for patients with type 2 diabetes mellitus
Ponssen, H., ELTE, J., Lehert, P., Schouten, J. P., & Bets, D. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)90005-5 · Cited by 64
Basu, R., Shah, P., Basu, A., Norby, B., Dicke, B., Chandramouli, V., Cohen, O., Landau, B. R., & Rizza, R. A. (2008) · Diabetes · doi:10.2337/db07-0827 · Cited by 63
Mari, A., Nielsen, L. L., Nanayakkara, N., DeFronzo, R. A., Ferrannini, E., & Halseth, A. E. (2006) · Hormone and Metabolic Research · doi:10.1055/s-2006-956505 · Cited by 63
Relimpio, F., Pumar, A., Losada, F., Mangas, M. Á., Acosta, D., & Astorga, R. (1998) · Diabetic Medicine · Cited by 63
Derosa, G., Mugellini, A., Ciccarelli, L., Crescenzi, G., & Fogari, R. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00057-3 · Cited by 62
Explaining the Decline in Early Mortality in Men and Women With Type 2 Diabetes
Charlton, J., Latinovic, R., & Gulliford, M. C. (2008) · Diabetes Care · doi:10.2337/dc08-0137 · Cited by 60
Selby, J. V., Ettinger, B. B., Swain, B. E., & Brown, J. B. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.38 · Cited by 58
Prager, R., & Schernthaner, G. (1983) · Diabetes · doi:10.2337/diab.32.12.1083 · Cited by 58
Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes
Kvapil, M., Сватко, А., Hilberg, C., & Shestakova, M. V. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00492.x · Cited by 58
Betteridge, D. J., & Vergès, B. L. (2005) · Diabetologia · doi:10.1007/s00125-005-0034-1 · Cited by 57
Fisman, E. Z., Tenenbaum, A., Benderly, M., Goldbourt, U., Behar, S., & Motro, M. (1999) · Cardiology · doi:10.1159/000006909 · Cited by 57
Lam, K. S., Tiu, S., Tsang, M., Ip, T., & Tam, S. C. F. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1154 · Cited by 56
Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics
Gin, H., Freyburger, G., Boisseau, M., & Aubertin, J. (1989) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(89)90058-2 · Cited by 55
Sharma, P. K., Bhansali, A. K., Sialy, R., Malhotra, S., & Pandhi, P. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02658.x · Cited by 55
Effect of insulin–metformin combination on hepatic steatosis in patients with type 2 diabetes
Lingvay, I., Raskin, P., & Szczepaniak, L. S. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.02.005 · Cited by 55
Hollenbeck, C. B., Johnston, P., Varasteh, B. B., Chen, Y. I., & Reaven, G. M. (1991) · PubMed · Cited by 55
Collier, A., WATSON, H. H. K., Patrick, A. W., Ludlam, C. A., & Clarke, B. F. (1989) · PubMed · Cited by 55
Esposito, K., Ciotola, M., Maiorino, M. I., Gualdiero, R., Schisano, B., Ceriello, A., Beneduce, F., Feola, G., & Giugliano, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-8-200810210-00005 · Cited by 54
Kudolo, G. B., Wang, W., Javors, M. A., & Blodgett, J. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2005.12.012 · Cited by 54
Papathanassiou, K., Naka, K. Κ., Kazakos, N., Kanioglou, C., Makriyiannis, D., Pappas, K. D., Katsouras, C. S., Liveris, K., Kolettis, T. M., Tsatsoulis, A. A., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.027 · Cited by 53
Eurich, D. T., Simpson, S. H., Majumdar, S. R., & Johnson, J. A. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.6.810 · Cited by 53
Phillips, S. A., Kung, J., Ciaraldi, T. P., Choe, C. H., Christiansen, L., Mudaliar, S. R. D., & Henry, R. R. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00378.2009 · Cited by 53
Féry, F., Plat, L., & BALASSE, E. O. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90307-3 · Cited by 52
Nauck, M. A., Holst, J. J., & Willms, B. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979067 · Cited by 52
FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE
Chakrabarti, R., Hocking, E., & Fearnley, G. R. (1965) · The Lancet · doi:10.1016/s0140-6736(65)92383-4 · Cited by 52
Aarsand, A. K., & Carlsen (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00361.x · Cited by 52
Fanghänel, G., Sánchez‐Reyes, L., Trujillo, C., Sotres, D. A., & Espinosa-Campos, J. (1996) · Diabetes Care · doi:10.2337/diacare.19.11.1185 · Cited by 51
SCHNEIDER, J., Erren, T. C., Zöfel, P., & Kaffarnik, H. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90148-c · Cited by 51
Berhanu, P., Pérez, A., & Yu, S. S. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00633.x · Cited by 51
Luna, V., Casauban, L., Sajan, M. P., Gomez-Daspet, J., Powe, J. L., Miura, A., Rivas, J., Standaert, M. L., & Farese, R. V. (2006) · Diabetologia · doi:10.1007/s00125-005-0112-4 · Cited by 50
Hamann, A., García‐Puig, J., Paul, G., Donaldson, J., & Stewart, M. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-984441 · Cited by 49
Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics
Standl, E., Schernthaner, G.-H., Rybka, J., Hanefeld, M., Raptis, S., & Naditch‐Brûlé, L. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00231-x · Cited by 49
Feinglos, M. N., DAILEY, G. E., Cefalu, W. T., Osei, K., Tayek, J. A., Canovatchel, W. J., Chaiken, R. L., & KOURIDES, I. A. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.09.002 · Cited by 49
Balancing Risk and Benefit with Oral Hypoglycemic Drugs
Hamnvik, O. R., & McMahon, G. T. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20116 · Cited by 48
Miglitol combined with metformin improves glycaemic control in type 2 diabetes
Gaal, L. V., Maislos, M., Schernthaner, G., Rybka, J., & Segal, P. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00141.x · Cited by 47
Comparison of Combined Therapies in Treatment of Secondary Failure to Glyburide
Trischitta, V., Italia, S., Mazzarino, S., Buscema, M., Rabuazzo, A. M., Sangiorgio, L., Squatrito, S., & Vigneri, R. (1992) · Diabetes Care · doi:10.2337/diacare.15.4.539 · Cited by 47
Rains, S. G. H., Wilson, G. A., Richmond, W., & Elkeles, R. S. (1989) · Journal of the Royal Society of Medicine · doi:10.1177/014107688908200213 · Cited by 47
Lund, S. S., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C., Frandsen, M., Smidt, U., Pedersen, O. B., Parving, H. ‐., & Vaag, A. A. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00713.x · Cited by 46
Khanolkar, M., Morris, R. H. K., Thomas, A. W., Bolusani, H., Roberts, A. W., Geen, J., Jackson, S. K., & Evans, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.020 · Cited by 46
Taylor, K. G., John, W. G., Matthews, K. A., & Wright, A. D. (1982) · Diabetologia · doi:10.1007/bf00254300 · Cited by 46
Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes.
Lord, J. M., White, S. I., Bailey, C. J., Atkins, T. W., Fletcher, R. F., & Taylor, K. G. (1983) · BMJ · doi:10.1136/bmj.286.6368.830 · Cited by 46
Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes
English, P., Ashcroft, A., Patterson, M., Dovey, T. M., Halford, J. C. G., Harrison, J., Eccleston, D., Bloom, S. R., Ghatei, M. A., & Wilding, J. P. H. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.681 · Cited by 46
Farah, R. E., Shurtz-Swirski, R., & Lapin, O. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-20 · Cited by 45
The Effects of Dexfenfluramine on Blood Glucose Control in Patients with Type 2 Diabetes
Willey, K. A., Molyneaux, L. M., Overland, J., & Yue, D. K. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01793.x · Cited by 45
Belsey, J., & Krishnarajah, G. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00884.x · Cited by 44
Changes in Weight and Glucose Tolerance During Treatment With Mirtazapine
Himmerich, H., Fulda, S., Schaaf, L., Beitinger, P. A., Schuld, A., & Pollmächer, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.1.170 · Cited by 44
Sundaresan, P., Lykos, D., Daher, A., Diamond, T., Morris, R., & Howes, L. G. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.692 · Cited by 43
Population Exposure‐Response Modeling of Metformin in Patients With Type 2 Diabetes Mellitus
Hong, Y., Rohatagi, S., Habtemariam, B. A., Walker, J. R., Schwartz, S. L., & Mager, D. E. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008316884 · Cited by 43
Pedersen, O., Nielsen, O. H., Bak, J. F., Richelsen, B., Beck‐Nielsen, H., & Sørensen, N. S. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb01156.x · Cited by 42
Trischitta, V., Gullo, D., PEZZINO, V., & Vigneri, R. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-4-713 · Cited by 41
Horton, E. S., Foley, J. E., Shen, S. G., & Baron, M. A. (2004) · Current Medical Research and Opinion · doi:10.1185/030079903125003881 · Cited by 41
Papa, G. F. S., Fedele, V., Chiavetta, A., Lorenti, I., Leotta, C., Luca, S., Rabuazzo, A. M., Piro, S., Alagona, C., Spadaro, L., et al. (2008) · Acta Diabetologica · doi:10.1007/s00592-007-0023-6 · Cited by 41
Li, K., Li, L., Yang, M., Zong, H., Liu, H., & Yang, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0335 · Cited by 41
Kusaka, I., Nagasaka, S., Horie, H., & Ishibashi, S. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00857.x · Cited by 40
Determination of Plasma Metformin by a New Cation-Exchange HPLC Technique
Bonfigli, A. R., Manfrini, S., Gregorio, F., Testa, R., Testa, I., Sio, G. D., & Coppa, G. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199906000-00015 · Cited by 40
Bermúdez, V., Cano, C., Medina, M. T., Souki, A. J., Lemus, M. A., Leal, E., Seyfi, H., Cano, R., Ciscek, A., Arias, F. B., et al. (2007) · American Journal of Therapeutics · doi:10.1097/01.pap.0000249909.54047.0e · Cited by 40
Michel Komajda, N., Curtis, P. S., Markolf Hanefeld, E., Beck‐Nielsen, H., Pocock, S., Zambanini, A., Jones, N. P., Gomis, R., Home, P., & For The RECORD Study Group (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-10 · Cited by 40
Short‐term effects of metformin in type 2 diabetes
Eriksson, A. W., Attvall, S., Bonnier, M., Eriksson, J. W., Rosander, B., & Karlsson, F. A. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00624.x · Cited by 40
Biguanide related lactic acidosis: incidence and risk factors.
Aguilar, C., Reza, A., Garcia, J. E. T., & Rull, J. A. (1992) · PubMed · Cited by 39
Noury, J., & Nandeuil, A. (1991) · PubMed · Cited by 39
Adamia, N., Virsaladze, D., Charkviani, N., Схиртладзе, М. Р., & Khutsishvili, M. P. (2007) · PubMed · Cited by 39
Rigas, A. N., Bittles, A. H., Hadden, D. R., & Montgomery, D. A. D. (1968) · BMJ · doi:10.1136/bmj.4.5622.25 · Cited by 39
Hermann, L. S., Karlsson, J. E., & Sj�strand, �. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315441 · Cited by 39
Belcher, G., & Schernthaner, G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01595.x · Cited by 39
Uehara, M. H., Kohlmann, N. E. B., Zanella, M. T., & Ferreira, S. R. G. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00136.x · Cited by 38
Repaglinide in combination therapy with metformin in Type 2 diabetes
Moses, R. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212169 · Cited by 38
Comparative efficacy of glimepiride and/or metformin with insulin in type 2 diabetes
Kabadi, U. M., & Kabadi, M. U. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.10.024 · Cited by 38
Adding Liraglutide to Oral Antidiabetic Drug Monotherapy: Efficacy and Weight Benefits
Nauck, M. A., & Marre, M. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.05.1997 · Cited by 38
Harris, S. B., Yale, J., Dempsey, E., & Gerstein, H. C. (2008) · PubMed · Cited by 38
Monotherapy with Metformin: Does It Improve Hypoxia in Type 2 Diabetic Patients?
Ćosić, V., Antić, S., Pesić, M., Jovanović, O., Kundalić, S., & Djordjević, V. B. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.135 · Cited by 38
EGUCHI, K., Tomizawa, H., Ishikawa, J., Hoshide, S., Numao, T., Fukuda, T., Shimada, K., & Kario, K. (2007) · Hypertension Research · doi:10.1291/hypres.30.23 · Cited by 37
Nagi, D., Mohamed‐Ali, V., & Yudkin, J. S. (1996) · Diabetic Medicine · Cited by 37
Schwarz, S. L., Gerich, J. E., Marcellari, A., Jean-Louis, L., Purkayastha, D. S., & Baron, M. A. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00792.x · Cited by 37
Stewart, M. W., Cirkel, D. T., Furuseth, K., Donaldson, J., Biswas, N., Starkie, M., Phenekos, C., & Hamann, A. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01942.x · Cited by 37
Raskin, P., Matfin, G., Schwartz, S. L., CHAYKIN, L. B., Chu, P. ‐., Braceras, R., & Wynne, A. G. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00796.x · Cited by 36
Gin, H., Slama, G., Weissbrodt, P., Poynard, T., Vexiau, P., Klein, J. C., & Tchobroutsky, G. (1982) · Diabetologia · doi:10.1007/bf00257727 · Cited by 36
Erle, G., Lovise, S., Stocchiero, C., Lora, L., Coppini, A., Marchetti, P., & Merante, D. (1999) · Acta Diabetologica · doi:10.1007/s005920050146 · Cited by 36
Metformin and Lactic Acidosis: Guilt by association?
Stacpoole, P. W. (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1587 · Cited by 36
Gupta, A., Smith, S. R., Greenway, F. L., & Bray, G. A. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00965.x · Cited by 35
Erdem, G., Doğru, T., Taşçı, İ., Bozoğlu, E., Muhsiroğlu, Ö., Tapan, S., Erçin, C. N., & Sönmez, A. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.07.021 · Cited by 35
Kim, H. J., Kim, S. K., Shim, W. S., Lee, J. H., Hur, K. Y., Kang, E. S., Ahn, C. W., Lim, S. K., Lee, H. C., & Soo, B. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.02.001 · Cited by 35
He, Y., Sabo, R., Picard, F., Wang, Y., Herron, J. M., Ligueros‐Saylan, M., & Dole, W. P. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902869102 · Cited by 35
Ohira, M., Miyashita, Y., Ebisuno, M., Saiki, A., Endo, K., Koide, N., Oyama, T., Murano, T., Watanabe, H., & Shirai, K. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.02.012 · Cited by 34
Clauson, P., Karlander, S. G., Steen, L., & Efendić, S. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199605)13:5<471::aid-dia103>3.0.co;2-t · Cited by 34
Jansson, P., Gudbjörnsdóttir, H. S., Andersson, O. K., & Lönnroth, P. (1996) · Diabetes Care · doi:10.2337/diacare.19.2.160 · Cited by 34
One‐year Acarbose Treatment Raises Fasting Serum Acetate in Diabetic Patients
Wolever, T. M. S., Radmard, R., Chiasson, J. L., Hunt, J. A., Josse, R. G., Palmason, C., Rodger, N. W., Ross, S., Ryan, E. A., & Tan, M. H. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00448.x · Cited by 33
Intensive insulin therapy combined with metformin in obese type 2 diabetec patients
Fritsche, A., Schmülling, R.-M., Häring, H., & Stümvoll, M. (2000) · Acta Diabetologica · doi:10.1007/s005920070030 · Cited by 33
Seufert, J., & Urquhart, R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.11.014 · Cited by 33
Bell, D. S. H., & Mayo, M. S. (1997) · Endocrine Practice · doi:10.4158/ep.3.2.73 · Cited by 32
Gregorio, F., Ambrosi, F., Marchetti, P., Cristallini, S., Navalesi, R., Brunetti, P., & Filipponi, P. (1990) · Acta Diabetologica · doi:10.1007/bf02581286 · Cited by 32
Magalhães, F. D. C., Gouveia, L., Torquato, M. T. D. C. G., Paccola, G. M. G. F., Piccinato, C. E., & Foss, M. (2006) · Hormone and Metabolic Research · doi:10.1055/s-2006-949522 · Cited by 32
Viljanen, A. P. M., Virtanen, K. A., Järvisalo, M. J., Hällsten, K., Parkkola, R. K., Rönnemaa, T., Lönnqvist, F., Iozzo, P., Ferrannini, E., & Nuutila, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1073 · Cited by 32
COMBINED METFORMIN-CHLORPROPAMIDE THERAPY IN 108 DIABETIC SULPHONYLUREA-FAILURES
Clarke, B. F., & Duncan, L. J. P. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91893-3 · Cited by 31
Kaku, K. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902820816 · Cited by 31
Ristic, S., Collober‐Maugeais, C., Cressier, F., Tang, P., & Pecher, E. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00632.x · Cited by 31
Kadoglou, N. P. E., Iliadis, F. S., ANGELOPOULOU, N. A., Perrea, D. N., Liapis, C. D., & Alevizos, M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02375.x · Cited by 31
Calle‐Pascual, A. L., Garcia-Honduvilla, J., Martin-Alvarez, P. J., Vara, E., Calle, J. R., Munguira, M. E., & Marañes, J. P. (1995) · PubMed · Cited by 31
Gao, H., Xiao, W., Wang, C., Zhang, J., Yang, Y., Yang, J. O., Yang, W., & Hong, T. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01733.x · Cited by 30
Wulffelé, M. G., Kooy, A., Lehert, P., Bets, D., Donker, A. J. M., & Stehouwer, C. D. A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01554.x · Cited by 30
Santos, R. F., Nomizo, R., Wajhenberg, B. L., Reaven, G. M., & Azhar, S. (1995) · PubMed · Cited by 29
Júnior, C. A. M., de Sá, J. R., Guedes, O. M. S., & Dib, S. A. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000400009 · Cited by 29
Triplitt, C. L., Glass, L. C., Miyazaki, Y., Wajcberg, E., Gastaldelli, A., Filippis, E. D., Cersósimo, E., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-0564 · Cited by 29
Garcia‐Soria, G., González-Gálvez, G., Argoud, G., Gerstman, M., Littlejohn, T. W., Schwartz, S. L., O'Farrell, A. M., Li, X., Cherrington, J. M., Bennett, C., et al. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00868.x · Cited by 29
Metformin treatment in NIDDM patients with mild renal impairment
Connolly, V., & Kesson, C. M. (1996) · Postgraduate Medical Journal · doi:10.1136/pgmj.72.848.352 · Cited by 29
Clinical experience with acarbose: results of a Canadian multicentre study.
Rodger, N. W., Chiasson, J. L., Josse, R. G., Hunt, J. A., Palmason, C., Ross, S. A., Ryan, E., Tan, M., & Wolever, T. M. S. (1995) · PubMed · Cited by 29
Wolever, T. M. S., Chiasson, J., Josse, R. G., Hunt, J. A., Palmason, C., Rodger, N. W., Ross, S. A., Ryan, E. A., & Tan, M. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1612 · Cited by 28
Pala, L., Mannucci, E., Dicembrini, I., & Rotella, C. M. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.02.010 · Cited by 28
Metformin added to insulin therapy in poorly controlled type 2 diabetes.
Hirsch, I. B. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.854b · Cited by 28
Willey, K. A., Molyneaux, L. M., & Yue, D. K. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00336.x · Cited by 28
Cavallo‐Perin, P., Aluffi, E., Estivi, P., Bruno, A. M., Carta, Q., Pagano, G., & Lenti, G. (1989) · PubMed · Cited by 28
Trischitta, V., Italia, S., Raimondo, M., Guardabasso, V., Licciardello, C., Runello, F., Mazzarino, S., Sangiorgi, L., Anello, M., & Vigneri, R. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03348039 · Cited by 27
Stefanović, V., Antić, S., Mitić-Zlatković, M., & Vlahović, P. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199911/12)15:6<400::aid-dmrr66>3.0.co;2-4 · Cited by 27
The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action
Ohnhaus, E. E., Berger, W., Duckert, F., & Oesch, F. (1983) · Journal of Molecular Medicine · doi:10.1007/bf01537460 · Cited by 27
Groop, L., & Widén, E. (1991) · PubMed · Cited by 27
Bermúdez, V., Cano, R., Cano, C., Bermúdez, F., Leal, E., Acosta, K., Mengual, E., Arráiz, N., Briceño, C., Rivas, J. G., et al. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318160b909 · Cited by 26
Derosa, G., Maffioli, P., SALVADEO, S. A. T., Ferrari, I., Gravina, A., Mereu, R., Palumbo, I., D’Angelo, A., & Cicero, A. F. G. (2009) · Metabolism · doi:10.1016/j.metabol.2009.03.007 · Cited by 26
Velojić-Golubović, M., Mikic, D., Pesic, M., Dimić, D., Radenković, S., & Antić, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345673 · Cited by 26
Damsbo, P., Hermann, L. S., Vaag, A. A., Nielsen, O. H., & Beck‐Nielsen, H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1489 · Cited by 26
Metformin in Treatment of Diabetes Mellitus
Gottlieb, B., & Auld, W. (1962) · BMJ · doi:10.1136/bmj.1.5279.680 · Cited by 26
Gibson, M., Westwood, M., Crosby, S. R., Gordon, C., Holly, J. M. P., Fraser, W. A., Anderson, C., White, A. E., & Young, R. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7536208 · Cited by 26
Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes.
Fanghänel, G., Silva, U., Sánchez‐Reyes, L., Sisson, D., Sotres, D. A., & Em, T. (1998) · PubMed · Cited by 26
Hermann, L. S., Bitzén, P. ‐., Kjellström, T., Lindgärde, F., & Scherstén, B. (1991) · PubMed · Cited by 25
Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes.
McBain, A. M., Brown, I. R. F., Menzies, D. G., & Campbell, I. W. (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.9.933 · Cited by 25
Derosa, G., SALVADEO, S. A. T., D’Angelo, A., Fogari, E., Ragonesi, P. D., Ciccarelli, L., Piccinni, M. N., Ferrari, I., Gravina, A., Maffioli, P., et al. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.12.009 · Cited by 25
Acarbose for the treatment of Type II diabetes: the results of a Canadian multi-centre trial
Josse, R. G. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01081-n · Cited by 25
Hsieh, C., He, C.-T., Lee, C.-H., Wu, L., & Hung, Y. (2007) · Metabolism · doi:10.1016/j.metabol.2007.03.018 · Cited by 25
Metformin Reduces Circulating Factor VII Concentrations in Patients with Type 2 Diabetes mellitus
Grant, P. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615172 · Cited by 24
Lin, K., Chang, Y., Wang, C.-L., Yang, Y., Hsiao, P., Li, T.-H., & Shin, S. (2008) · Translational research · doi:10.1016/j.trsl.2008.04.003 · Cited by 24
Testa, R., Bonfigli, A. R., PIANTANELLI, L., Manfrini, S., Testa, I., & Gregorio, F. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01286-7 · Cited by 24
Teupe, B., & Bergis, K. (1991) · PubMed · Cited by 24
Rosak, C., Petzoldt, R., Wolf, R., Reblin, T., Dehmel, B., & Seidel, D. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00652.x · Cited by 23
Johnson, M. L., Krosnick, A., Carson, P., McDade, A. M., & Laraway, K. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80132-x · Cited by 23
Roden, M., Laakso, M., Johns, D., Widel, M., Urquhart, R., Richardson, C., Mariz, S., & Tan, M. H. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01610.x · Cited by 23
Mashavi, M., Hanah, R., Boaz, M., Gavish, D., Matas, Z., Fux, A., & Shargorodsky, M. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.037 · Cited by 23
Derosa, G., Gaddi, A., Ciccarelli, L., Fogari, E., Ghelfi, M., Ferrari, I., & Cicero, A. F. G. (2005) · Journal of International Medical Research · doi:10.1177/147323000503300303 · Cited by 23
THE EFFECT OF METFORMIN ON WEIGHT LOSS IN OBESITY
Pedersen, J. (1965) · European Journal of Endocrinology · doi:10.1530/acta.0.0490479 · Cited by 23
Hermann, L. S., Kjellström, T., & Nilsson‐Ehle, P. (1991) · PubMed · Cited by 22
Treatment of non-insulin-dependent diabetes mellitus with metformin.
Guthrie, R. M. (1997) · PubMed · Cited by 22
Cho, Y. W., Yang, D. H., Oh, D. Y., Baick, S. H., Kim, S. K., Kim, S. J., & Hong, S. Y. (1992) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.1992.7.2.81 · Cited by 22
Vigneri, R., Trischitta, V., Italia, S., Mazzarino, S., Rabuazzo, A. M., & Squatrito, S. (1991) · PubMed · Cited by 21
Shimpi, R. D., Patil, P. H., Kuchake, V. G., Ingle, P. V., Surana, S. J., & Dighore, P. N. (2009) · International Journal of PharmTech Research · Cited by 21
Home, P., Bailey, C. J., Donaldson, J., Chen, H., & Stewart, M. W. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02141.x · Cited by 21
Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulphonylurea therapy
Leslie, P. J., Jung, R. T., Isles, T. E., & Baty, J. D. (1987) · Clinical Science · doi:10.1042/cs0730041 · Cited by 21
Civera, M., Merchante, Á. M., Salvador, M., Sanz, J., & Martínez, I. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.07.001 · Cited by 20
McAlpine, L. G., McAlpine, C., Waclawski, E., Storer, A., Kay, J., & Frier, B. M. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00614548 · Cited by 20
Metformin-Induced Lacticacidemia in Patients with Type 2 Diabetes Mellitus
Abbasi, A. A., Riyadh, K., & Sotingeanu, D. G. (2000) · Endocrine Practice · doi:10.4158/ep.6.6.442 · Cited by 20
Stålhammar, J., Bergman, U., Boman, K., & Dahlén, M. (1991) · Diabetes Care · doi:10.2337/diacare.14.1.12 · Cited by 20
Metformin and Insulin: Is There a Role for Combination Therapy?
Daniel, J. R., & Hagmeyer, K. O. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100414 · Cited by 20
Meshram, D. M., Langade, D., Kinagi, S., Naikwadi, A. A., Morye, V., & Chopra, D. (2005) · PubMed · Cited by 19
Derosa, G., D’Angelo, A., Fogari, E., SALVADEO, S. A. T., Gravina, A., Ferrari, I., & Cicero, A. F. G. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0320 · Cited by 19
Guillausseau, P.-J. (1997) · Diabetic Medicine · Cited by 19
Bj�rntorp, P., Carlstr�m, S., Fagerberg, S., Hermann, L. S., Holm, A., Scherst�n, B., & �stman, J. (1978) · Diabetologia · doi:10.1007/bf00422252 · Cited by 19
Roden, M., Mariz, S., Brazzale, A. R., & Pacini, G. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02040.x · Cited by 19
Wolever, T. M. S., Assiff, L., Basu, T. K., Chiasson, J., Boctor, M., Gerstein, H. C., Hunt, J. A., Josse, R. G., Lau, D. C. W., Leiter, L. A., et al. (2000) · Nutrition Research · doi:10.1016/s0271-5317(00)80025-1 · Cited by 19
Forti, A. C. E., Garcia, E. G., Yu, M. B., Jiménez, M. C. H., Brodows, R. G., & Oliveira, J. H. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802282398 · Cited by 19
Lewin, A. J., Lipetz, R. S., Wu, J., & Schwartz, S. L. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.05.013 · Cited by 19
Rizkalla, S. W., Elgrably, F., Tchobroutsky, G., & Slama, G. (1986) · PubMed · Cited by 19
Johansen, K. B. (1984) · PubMed · Cited by 19
DOUBLE‐BLIND TRIAL OF METFORMIN IN THE THERAPY OF NONKETOTIC DIABETICS
Higginbotham, L., & Martin, F. I. R. (1979) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1979.tb134534.x · Cited by 19
Vannasaeng, S., Ploybutr, S., Nitiyanant, W., Peerapatdit, T., & Vichayanrat, A. (1995) · PubMed · Cited by 18
Kemal, Y., Demirağ, N. G., Yı́ldı́rı́r, A., Atar, A., Ünal, A. D., & Biyiklioglu, Z. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0256-4 · Cited by 18
Yener, S., Çömlekçi, A., Akıncı, B., Akan, P., Demir, T., Bayraktar, F., & Yeşil, S. (2008) · HORMONES · doi:10.14310/horm.2002.1111039 · Cited by 18
Menzies, D. G., Campbell, I. W., McBain, A. M., & Brown, I. R. F. (1989) · Current Medical Research and Opinion · doi:10.1185/03007998909115209 · Cited by 18
A comparison of phenformin and metformin in the treatment of maturity onset diabetes.
Cairns, S., Shalet, S. M., Marshall, A. J., & Hartog, M. (1977) · PubMed · Cited by 17
Kawai, T., Funae, O., Shimada, A., Tabata, M., Hirata, T., Atsumi, Y., & Itoh, H. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0969 · Cited by 17
Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes
Basu, R., Basu, A., Chandramouli, V., Norby, B., Dicke, B. A., Shah, P. J., Cohen, O., Landau, B. R., & Rizza, R. A. (2008) · Diabetologia · doi:10.1007/s00125-008-1138-1 · Cited by 17
Gregorio, F., Ambrosi, F., Manfrini, S., Santucci, A., & Filipponi, P. (1997) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(97)00047-8 · Cited by 17
Pioglitazone reduces monocyte activation in type 2 diabetes
Pitocco, D., Giubilato, S., Zaccardi, F., Stasio, E. D., Buffon, A., Biasucci, L. M., Liuzzo, G., Crea, F., & Ghirlanda, G. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0058-3 · Cited by 17
Yener, S., Çömlekçi, A., Akıncı, B., Demir, T., Yüksel, F., Özcan, M. A., Bayraktar, F., & Yeşil, S. (2009) · Medical Principles and Practice · doi:10.1159/000215722 · Cited by 17
METFORMIN COMPARED WITH TOLBUTAMIDE IN THE TREATMENT OF MATURITY‐ONSET DIABETES MELLITUS
Lim, P., & Khoo, O. T. (1970) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1970.tb77850.x · Cited by 17
Boyd, K., Rogers, C., Boreham, C. A. G., Andrews, W. J., & Hadden, D. R. (1992) · PubMed · Cited by 16
Comaschi, M., Demicheli, A., Pietro, C. D., Bellatreccia, A., Mariz, S., & the COM06 Study Investigators (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.0023 · Cited by 16
de Muckadell, O. B. S., Mortensen, H. B., & LYNGSØE, J. (1979) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1979.tb13509.x · Cited by 16
A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin
Davies, M. J., Thaware, P. K., Tringham, J. R., Howe, J., Jarvis, J., Johnston, V., Kitchener, D. L., Skinner, T. C., McNally, P. G., & Lawrence, I. G. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02128.x · Cited by 16
Chan, J., Leyk, M., Frier, B. M., & Tan, M. H. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.929 · Cited by 16
Tessari, P., Biolo, G., Bruttomesso, D., Inchiostro, S., Panebianco, G., Vedovato, M., Fongher, C., & Tiengo, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989455 · Cited by 15
Vähätalo, M., Rönnemaa, T., & Viikari, J. S. A. (2007) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430701507719 · Cited by 15
Comaschi, M., Corsi, A. M., Pietro, C. D., Bellatreccia, A., & Mariz, S. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.04.003 · Cited by 15
Cunha, M. R., Silva, M. E. R., Machado, H. A., Fukui, R. T., Correia, M. R. S., Santos, R. F., WAJCHENBERG, B. L., Rocha, D. M., Rondon, M. U. P. B., Negrão, C. E., et al. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00690.x · Cited by 15
Wilson, J., Scott, M., & Gray, R. E. (1989) · Hormone and Metabolic Research · doi:10.1055/s-2007-1009224 · Cited by 15
Ciclazindol: An oral agent with weight reducing properties and hypoglycaemic activity
Lean, M. E. J., & Borthwick, L. J. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544012 · Cited by 15
Balasubramanian, R., Varadharajan, S., Kathale, A., Nagraj, L. M., Periyandavar, I., Nayak, U. P., Sharma, A., Bolmall, C., & Baliga, V. P. (2008) · PubMed · Cited by 15
Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes?
Jk, K., Pearce, K. A., Michielutte, R., & Summerson, J. H. (1999) · PubMed · Cited by 15
Research works printed but not linked: 44
- Abbink, 2000, Vascular effects of glibenclamide, glimepiride, metformin and acarbose in Type 2 DM patients, Diabetologia, 43, A39
- Andras, 1962, [Experience with biguanide treatment for diabetes mellitus], Orvosi hetilap, 103, 1029
- Bacci, 1961, [N.N. dimethyl-biguanide (DMGG) in the treatment of Diabetes meliitus], Minerva Medica, 52, 2770
- Boronat, 2000, [Effectiveness of treatment with metformin in patients with type 2 diabetes mellitus poorly controlled with insulin treatment], Revista Clinica Espanola, 200, 74
- Botha, 1977, Association of lactic acidosis with biguanide therapy [letter], South African Medical Journal, 52, 301
- Campbell, 1988, Effects of metformin on blood pressure and microalbuminuria in diabetes mellitus, Diabete & Metabolisme, 14, 613
- Canivet, 1962, [The treatment of Diabetes mellitus: Statistical results after a review of 1190 cases], La Presse Medicale, 70, 2038
- Davidson, 2000, Effect of metformin/glyburide tablets on HBA1c in first-line treatment of Type 2 Diabetes, Diabetologia, 43, A184
- DeFronzo, 1993, Combined metformin/glyburide treatment in NIDDM patients not optimally responding to maximum dose sulfonyluria: Results of a multicenter trial., Diabetes, 42, 146A (abs 455)
- 1993, Efficacy and safety of metformin in NIDDM: Results of a muticenter trial, Diabetes, 42, Abs 178
- Dornan, 1988, Metformin monotherapy for obese non-insulin-dependent diabetes. A double-blind evaluation, Diabetic Medicine, 5, 5 (Abs A17)
- Eriksson, 2007, Short-term effects of metformin in type 2 diabetes, Diabetes, Obesity & Metabolism, 9, 483, 10.1111/j.1463-1326.2006.00624.x · DOI
- Ferner, 1988, Impaired beta-cell responses improve when fasting blood glucose concentration is reduced in non-insulin-dependent diabetes, Quarterly Journal of Medicine, 66, 137
- Gursoy, 2000, The effect of metformin on insulin resistance and serum lipid profiles, Diabetologia, 43, A150
- Herman, 1961, Dimethyldiguanide (Glucophage, LA 6023) in Diabetes mellitus, South African Medical Journal, 35, 286
- Hu, 2008, [Effect of insulin plus rosiglitazone or metformin on serum N-terminal pro-brain natriuretic peptide in type 2 diabetes mellitus: a randomized-controlled study]. [Chinese], Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering, 25, 682
- Jackson, 1962, Combined oral therapy in Diabetes, South African Medical Journal, 36, 727
- Jones, 2000, Long-term efficacy of rosiglitazone as monotherapy or in combination with metformin, Diabetologia, 43, A192
- Jones, 2000, Addition of rosiglitazone to metformin is effective in obese, insulin-resistant patients with Type 2 Diabetes, Diabetologia, 43, A191
- Kooy, 2009, Increase in value of adding metformin to insulin therapy in type 2 diabetes: More favorable weight with less macrovascular complications, Nederlands Tijdschrift voor Geneeskunde, 153, 1005
- Marena, 1994, Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes [see comments], Diabete & Metabolisme, 20, 15
- Mughal, 2000, The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabtic patients with sub-optimal metabolic control, Journal of the Pakistani Medical Association, 50, 381
- Pirart, 1961, [A new oral antidiabetic medicine: N.N. Dimethylbiguanide. Clinical trial alternating a placebo with a sulfamide], Acta Clinica Belgica, 16, 575
- Siedradzki, 1999, [Assessment of efficacy and safety of acarbose in the treatment of diabetes mellitus. Observation study in the conditions of general health care], Przeglad Lekarski, 56, 335
- Sterne, 1963, [Report on five years experience with Metformin], Wiener Medizinische Wochenschrift, 113, 599
- Stratmann, 1965, [Experience with Dimethylbiguanide in late failrues of oral diabetes therapy], Medizinische Welt, 49, 2743
- Wulffele, 2000, Metformin and insulin therapy decreases glycosylated hemoglobin and insulin requirement in Type 2 Diabetes, Diabetologia, 43, A184
- Debry, 1964, [Study of lactic acid levels on an empty stomach in diabetic patients treated with N-N-dimethylbiguanide], Diabete, 12, 239
- Debry, 1966, [Results of the treatment of Diabetes mellitus in the adult with the association of Metformin and sulfamides (concerning 197 cases)], Journal de Medicine de Lyon, 47, 407
- Debry, 1966, [Results of the treatment of Diabetes mellitus in the adult with metformin (concerning 202 cases0], Journal de Medicine de Lyon, 47, 395
- Isnard, 1996, [Long term treatment with biguanides in the natural evolution of non-insulin-dependent diabetes], Journ Annu Diabetol Hotel Dieu, 273
- Javaid, 2007, A comparative study of the effects of hypogycemic agents on serum electrolutes in the diabetic patients, Pakistani Journal of Pharmacological Science, 20, 67
- Lalau, 1994, Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis, Nephrology Dialysis and Transplantation, 9, 126
- Lapina, 2008, [Efficacy and safety of the use of metformin in patients with chronic heart failure and type 2 diabetes mellitus. results of the study "rational effective mulicomponent therapy in the battle against diabetes mellitus in patients with chronic heart failure"]. [Russian], Kardiologiia, 48, 58
- Messens, 1966, [Treatment of diabetes mellitus with N.N. dimethy-biguanide], Diabete, 14, 74
- Muntoni, 1965, [Dimethyl-biguanide in the treatment of diabetes mellitus], La Clinica terapeutica, 35, 227
- O'Connor, 1998, Care of adults with type 2 diabetes mellitus. A review of the evidence [see comments], Journal of Family Practice, 47, S13
- Orlikowska, 1966, [Influence of N.N. dimethyl biguandie on certain elements of lipid metabolism in diabetic patients], Le Diabete, 14, 183
- Rambert, 1961, [Treatment of diabetes mellitus with NN-dimethyl-diguanide. Experience of 177 cases], Semaine des Hospitaux de Paris, 37, 247
- Sharabashi, 2006, Retrospecitve review of metformin in inpatients and outpatients at the University of Michigan, Diabetes Care, 29, 170, 10.2337/diacare.29.01.06.dc05-1762 · doi:10.2337/diacare.29.01.06.dc05-1762
- Teitelbaum, 1963, [Biguanides and sulfamides in small doses in the initial treatment of diabetes in obese patients], Diabete, 11, 342
- 1999, Metformin hydrochloride, 2755
- Olivia, 1970, Lactic acidosis, American Journal of Medicine, 48, 208
- Sterne, 1959, [Treatment of Diabetes mellitus with N.N. Dimethyl Guanil Guanidine (LA 6023, glucophage)], Therapie, 14, 625
Cited by
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Chatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577
Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Kurella Tamura, M., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,779
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373
Metadata
- Authors
- Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter (posthumous), E. E.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2010-01-20
- Issue
- 1
- Pages
- CD002967-CD002967
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4233394038
- Cited by
- 434
- References
- 464
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.